Recent news and DD: IntelliCell BioSciences Files Pre-IND With FDA for Osteoarthritis Lead by Dr. James Andrews Quote: Aug 1, 2014 IntelliCell BioSciences, Inc. (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous stomovascular cells (SVCs) derived from the blood vessels found in adipose tissue, announced today that it has filed its pre-IND with the FDA for a clinical trial in osteoarthritis of the knee under an Investigational New Drug Application (IND). Dr. James Andrews, the legendary orthopedic surgeon will be the principal investigator for the study. inVentiv Health Clinical will serve as the Clinical Research Organization (CRO) for the conduction of this clinical trial in osteoarthritis of the knee in accordance of an Investigational New Drug.
The clinical trial will be conducted at the Pensacola Center of the Andrews' Research and Educational Institute in conjunction with Dr. Adam Anz and Dr. Josh Hackel, prominent physicians at the Institute. To date, IntelliCell's technology for isolating stromal vascular fraction cells from the vasculature of adipose tissue has been used to successfully treat over 60 knees with results lasting as long as 5 years.
Sports Illustrated References IntelliCell BioSciences Technology for Athletes Quote: Jul 31, 2014 IntelliCell Biosciences, Inc. (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular cells (SVCs) derived from the blood vessels found in adipose tissue, announced that this week Sports Illustrated featured its cellular technology and gives credit to the inventor and IntelliCell CEO, Steven Victor, MD in the article "Stem Cell Treatment: Out from the Shadows, Onto the Cutting Edge". The article also features Dr. James Andrews and his notorious work with some of the most elite professional athletes in the sports industry.
Stem Cell Treatment: Out from the Shadows, Onto the Cutting Edge Quote:
Steven Victor, a dermatologist to celebrities, became involved with stem cells while seeking a use for discarded fat tissue from cosmetic procedures. He traveled to Greece for instruction, patented a technology in the U.S. that uses sound waves to isolate stem cells from the fat, and started the Park Avenue-based IntelliCell BioSciences. He’s treated current and former NFL players—Merril Hoge is a spokesperson—and, recently a Dubai businessman called about using the procedure to heal his high-priced thoroughbred racing camels.
His team of doctors is working on expanding and optimizing their stem-cell treatment options. Adam Anz, an orthopedic surgeon at the Andrews Institute, has traveled to Malaysia four times to learn from Khay Yong Saw, a surgeon who has had success repairing cartilage defects with the aid of stem cells harvested from the bloodstream. Josh Hackel, the primary care sports medicine physician who treats many of Andrews’ patients with stem cells from their bone marrow, has visited IntelliCell to learn more about its fat-derived stem cell technology. When Andrews’ biologics lab opens, clinical trials could begin on some of these new techniques with permission from the FDA—which Anz says he is close to getting for the cartilage innovation.
IntelliCell BioSciences announces That Merril Hoge has joined Its Board of Advisors Quote: May 13, 2014 IntelliCell BioSciences, Inc. (SVFC), a regenerative medicine company utilizing adult autologous stromal vascular fraction cells (SVFCs) derived from the blood vessels found in adipose tissue, announced today that Merril Hoge, former star NFL player and an on-air analyst for ESPN, has joined its Board of Advisors.
According to Merril Hoge, "After tearing a ligament in my elbow I tried to rehab it to avoid surgery. During rehab I came across Dr. Victor and started to learn more about Cell Therapy. After extensive research, I chose cell therapy on my elbow, and thank goodness I did. I avoided surgery and a year of rehab and now have a healthy, healed elbow. I am excited to join IntelliCell's Board of Advisors and believe that I can make a significant difference in helping other athletes."
IntelliCell BioSciences' Stromal Vascular Cell Technology Used For Restorative Cardiac Function With Dr. Zain Khalpey Quote: April 29, 2014 IntelliCell BioSciences, Inc. (SVFC), a regenerative medicine company utilizing adult autologous Stromal Vascular Cells (SVCs) derived from the blood vessels found in adipose tissue, announced today that it supplied its Stromal Vascular Fraction Cells, manufactured using its patented ultrasonic technology, for the restoration of cardiac function at the University of Arizona College of Medicine, Tucson in collaboration with Dr. Zain Khalpey, Division of Cardiothoracic Surgery. The autologous cells were gathered on site with Institutional Review Board approval in accordance with all applicable regulatory requirements. The case was reported in Clinical Communication to the Editor in The American Journal of Medicine Vol.127, No 5, May 2014.
This stock has had many "loading down here seems stupid not too" points over the past several months. All of those points were at much higher prices than the current price. I guess it will be true sooner or later. LOL.
News 
Market Data 
Discover 
